Abstract
Hair loss is a common clinical problem in women. Female alopecia with androgen increase is called female androgenetic alopecia (FAGA) and without androgen increase is called female pattern hair loss (FPHL). The clinical picture of typical FAGA begins with a specific “diffuse loss of hair from the parietal or frontovertical areas with an intact frontal hair implantation line”. Ludwig called this process “rarefaction”. In Ludwig’s classification of hair loss in women, progressive type of FAGA, 3 patterns were described: grade I or minimal, grade II or moderate and grade III or severe. Ludwig also described female androgenetic alopecia of male pattern (FAGA.M) that should be subclassified according to Ebling’s or Hamilton-Norwood classification. A more recent classification (Olsen’s classification of FPHL) proposes 2 types: early- and late-onset with or without excess of androgens in each. The diagnosis of FPHL is made by clinical history, clinical examination with measurement of natural female hairline, wash test, trichograms and laboratory test, especially androgenic determinations. Topical treatment of FPHL is with minoxidil 2–5% twice daily. When FAGA is associated with high levels of androgens, systemic antiandrogenic therapy is needed. Persistent adrenarche syndrome (adrenal SAHA – seborrhea, acne, hirsutism, alopecia) and alopecia of adrenal hyperandrogenism is treated with adrenal suppression and antiandrogens. Adrenal suppression is achieved with glucocorticosteroids. Antiandrogens therapy includes cyproterone acetate, drospirenone, spironolactone, flutamide, finasteride and dutasteride. Excess release of ovarian androgens (ovarian SAHA) and alopecia of ovarian hyperandrogenism is treated with ovarian suppression and antiandrogens. Ovarian suppression includes the use of contraceptives containing an estrogen, ethinylestradiol, and a progestogen. Antiandrogens such as cyproterone acetate, always accompanied by tricyclic contraceptives, are the best choice of antiandrogens to use in patients with FAGA. Gonadotropin-releasing hormone agonists such as leuprolide acetate suppress pituitary and gonadal function through a reduction in luteinizing hormone and follicle stimulating hormone levels. Subsequently, ovarian steroids levels also will be reduced, especially in patients with polycystic ovary syndrome. When polycystic ovary syndrome is associated with insulin resistance, metformin must be considered as treatment. Hyperprolactinemic SAHA and alopecia of pituitary hyperandrogenism should be treated with bromocriptine or cabergoline. Postmenopausal alopecia, with previous high levels of androgens or with prostatic-specific antigen greater than 0.04 ng/ml, improves with finasteride or dutasteride. Postmenopausal alopecia in normoandrogenic women also improves with finasteride at a dose of 2.5 mg per day, or dutasteride at dose of 0.5 mg per day. Weight loss undoubtedly improves hair loss in hyperandrogenic women.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AR:
-
Androgen receptor
- CA:
-
Cyproterone acetate
- CAH:
-
Congenital adrenal hyperplasia
- DHEA:
-
Dehydroepiandrosterone
- DHT:
-
Dihydrotestosterone
- Dx:
-
Dexamethasone
- EE:
-
Ethinyl estradiol
- FAGA:
-
Female androgenetic alopecia
- FAGA.M:
-
Female androgenetic alopecia of male pattern
- FPHL:
-
Female pattern hair loss
- FSH:
-
Follicle-stimulating hormone
- GnRH-a:
-
Gonadotropin-releasing hormone agonist
- LDL-C:
-
Low-density lipoprotein cholesterol
- LH:
-
Luteinizing hormone
- MAGA:
-
Male androgenetic alopecia
- OCP:
-
Oral contraceptive pill
- PCOS:
-
Polycystic ovary syndrome
- PSA:
-
Prostatic-specific antigen
- SAHA:
-
Seborrhea, acne, hirsutism, alopecia
- SHBG:
-
Sex hormone binding globulin
References
Ali, I., Dawber, R.P.R. and Wojnarowska, F.T., 2008. The role of the androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation pattern in postmenopausal female pattern hair loss: O-16. British Journal of Dermatology 159 (Suppl.1), 8–9.
Biondo, S., Goble, D. and Sinclair, R., 2004. Women who present with female pattern hair loss tend to underestimate the severity of their hair loss. British Journal of Dermatolology 150, 750–752.
Birch, M.P., Lalla, S.C. and Messenger, A.G., 2002. Female pattern hair loss. Clinical and Experimental Dermatology 27, 383–388.
Blume-Peytavi, U., Blumeyer, A., Tosti, A., Finner, A., Marmol, V., Trakatelli, M., Reygagne, P., Messenger, A. and the European Consensus Group, 2011. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. British Journal of Dermatology 164, 5–15.
Camacho, F., 2001. Hirsutismo. Enfoque clínico-terapéutico II. Actualidad Terapéutica Dermatológica (Argentina) 24, 190–206.
Camacho, F., 2008a. Hirsutism. In: Blume-Peytavi, U., Tosti, A., Whiting, D.A. and Trüeb, R. (eds.) Hair growth and disorders. Springer-Verlag, Berlin, Germany, pp. 357–377.
Camacho, F., 2008b. Hypertrichosis and hirsutism. In: Bolognia, J., Jorizzo, J.L. and Rapini, R.P. (eds.) Dermatology. Mosby, London, UK, pp. 1007–1018.
Camacho, F. and Rodríguez-Rey, E., 2007. Alopecias de patrón femenino en la adolescencia y mujer premenopáusica Monografías de Dermatología 20, 261–292.
Camacho-Martínez, F.M., 2009. Hair loss in women. Seminars in Cutaneous Medicine and Surgery 28, 19–32.
Camacho, F., López-Elorza, F., Rodríguez-Rey, E. and Coronel-Pérez, I.M., 2009. Prostate-specific antigen levels as hyperandrogenism marker in women. Journal of the European Academy of Dermatology and Venereology 23, 221–223.
Camacho, F. and Ludwig, E., 2005. Female pattern hair loss. Female androgenetic alopecia. Clinico-pathological features. Monografías de Dermatología 18, 54–74.
Camacho, F. and Tosti, A., 2005. Tratamiento médico de las alopecias femeninas. Monografías de Dermatologia 18, 92–117.
Cousen, P. and Messenger, A., 2010. Female pattern hair loss in complete androgen insensitivity syndrome. British Journal of Dermatology 162, 1135–1137.
El-Domyati, M., Attia, S., Saleh, F., Bassyouni, M., Barakat, M. and Abdel-Wahab, H., 2010. Evaluation of apoptosis regulatory markers in androgenetic alopecia. Journal of Cosmetic Dermatology 9, 267–275.
Eun, H.C., Kwon, O.S., Yeon, J.H., Shin, H.S., Kim, B.Y., Ro, B.I., Cho, H.K., Sim, W.Y., Lew, B.L., Lee, W.-S., Park, H.Y., Hong, S.P. and Ji, J.H., 2010. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology and Venereology 63, 252–258.
Georgala, S., Katuolis, A.C., Georgala, C., Moussatou, V., Bozi, E. and Stavrianeas, N.G., 2004. Topical estrogen therapy for androgenetic alopecia in menopausal females. Dermatology 208, 178–179.
Hillmer, A.M., Flaquer, A., Hanneken, S., Elgelshoven, S., Kortüm, A.-K., Brockschmidt, F.F., Golla, A., Metzen, C., Thiele, H., Kolberg, S., Reinartz, R., Betz, R.C., Ruzicka, T., Hennies, H.C., Kruse, R. and Nöthen, M.M., 2008. Genome-wid scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. The American Journal of Human Genetics 82, 737–743.
Hoffmann, R., 2003. TrichoScan: a novel tool for the analysis of hair growth in vivo. Journal of Investigative Dermatology Symposium Proceedings 8, 109–115.
Iorizzo, M., Vinzenci, C., Voudouris, S., Piraccini, B.M. and Tosti, A., 2006. Finasteride treatment of female pattern hair loss. Archives of Dermatology 142, 298–302.
Langan, E.A. and Paus, R., 2010. Female pattern hair loss: beyond and androgenic aetiology? British Journal of Dermatology 163, 1141–1142.
Levy-Nissenbaum, E., Bar-Natan, M., Frydman, M. and Pras, E., 2005. Confirmation of the association between male pattern baldness and the androgen receptor gene. European Journal of Dermatology 15, 339–340.
Lowenstein, E.J., 2006. Diagnosis and management of the dermatologic manifestation of the polycystic ovary syndrome. Dermatologic Therapy 19, 210–223.
Ludwig, E., 1977. Classification of the types of androgenetic alopecia (common baldness) ocurring in the female sex. British Journal of Dermatology 97, 247–254.
Mella, J.M., Perret, M.C., Manzotti, M., Catalana, H.N. and Guyatt, G., 2010. Efficacy and safety of finasteride therapy for androgenetic alopecia. Archives of Dermatology 146, 1141–1150.
Mirmirani, P., Huang, K.P. and Price, V.H., 2011. A practical algorithmic approach to diagnosing hair shaft disorders. International Journal of Dermatology 50, 1–12.
Moreno-Ramírez, D. and Camacho-Martínez, F., 2005. Frontal fibrosing alopecia: a survey in 16 patients. Journal of the European Academy of Dermatology and Venereology 19, 700–705.
Norwood, O.T., 2001. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatologic Surgery 27, 53–54.
Nusbaum, B.P. and Fuentefria, S., 2009. Naturally occuring female hairline patterns. Dermatologic Surgery 35, 907–913.
Olsen, E.A., 1999. The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. Journal of the American Academy of Dermatology 40, 106–109.
Olsen, E.A., 2001. Female pattern hair loss. Journal of American Academy of Dermatology 45, S70-S80.
Olsen, E.A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M.L., Wilson, T. and Rittmaster, R.S., 2006. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology 55, 1014–1023.
Olszewska, M. and Rudnicke, L., 2005. Effective treatment of female androgenic alopecia with dutasteride. Journal of Drugs in Dermatology 4, 637–640.
Randall, V.A., 2008. Androgens and hair growth. Dermatologic Therapy 21, 314–328.
Rathnayake, D. and Sinclair, R., 2010. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Dermatologic Clinics 28, 611–618.
Rebora, A., Guarrera, M., Baldari, M. and Vecchio, F., 2005. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Archives of Dermatology 141, 1243–1245.
Riedel-Baima, B. and Riedel, A., 2009. Use of TrichoScan to assess female pattern hair loss. Dermatologic Surgery 35, 651–655.
Saraogi, P.P. and Dhurat, R.S., 2010. Automated digital image analysis (TrichoScan®) for human hair growth analysis: ease versus errors. International Journal of Trichology 2, 5–13.
Schweiger, E.S., Boychenko, O. and Bernstein, R.M., 2010. Update on the pathogenesis, genetics and medical treatment of patterned hair loss. Journal of Drugs in Dermatology 9, 1412–1419.
Sinclair, R.D. and Dawber, R.P.R., 2001. Androgenetic alopecia in men and women. Clinics in Dermatology 19, 167–178.
Sovak, M., Seligson, A.L., Kucerova, R., Bienova, M., Hajduch, M. and Bucek, M., 2002. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience. Dermatologic Surgery 28, 678–685.
Stefanato, C.M., 2010. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 56, 24–38.
Tosti, A., 2007. Dermoscopy of hair and scalp disorders with clinical and pathological correlations. Informe Healthcare, Bologna, Italy, pp. 15–25.
Trüeb, R.M., 2010. Systematic approach to hair loss in women. JDDG: Journal of the German Society of Dermatology 8, 284–297.
Westberg, L., Baghaei, F., Rosmond, R., Hellstrand, M., Landén, M., Jansson, M., Holm, G., Björntorp, P. and Eriksson, E., 2001. Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women. The Journal of Clinical Endocrinology & Metabolism 86, 2562–2568.
Yeon, J.H., Jung, J.Y., Choi, J.W., Kim, S.W., Park, K.C. and Huh, C.H., 2011. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. Journal of the European Academy of Dermatology and Venereology 25, 211–214.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2012 Wageningen Academic Publishers
About this chapter
Cite this chapter
Martínez, F.M.C. (2012). Hair loss in women. In: Preedy, V.R. (eds) Handbook of hair in health and disease. Human Health Handbooks no. 1, vol 1. Wageningen Academic Publishers. https://doi.org/10.3920/978-90-8686-728-8_4
Download citation
DOI: https://doi.org/10.3920/978-90-8686-728-8_4
Publisher Name: Wageningen Academic Publishers
Online ISBN: 978-90-8686-728-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)